---
figid: PMC9571264__molecules-27-06709-g013
pmcid: PMC9571264
image_filename: molecules-27-06709-g013.jpg
figure_link: /pmc/articles/PMC9571264/figure/molecules-27-06709-f013/
number: Figure 13
figure_title: ''
caption: 3D presentation of docked compounds (cyan-highlighted) inside the binding
  site of tested proteins; (A) compound 4 bound to PI3K key amino acid residues in
  the active site, (B) compound (8b) bound to PI3K key amino acid residues in the
  active site, (C) staurosporine (control) bound to PI3K key amino acid residues in
  the active site, (D) compound (4) bound to AKT key amino acid residues in the active
  site, (E) compound 8b bound to AKT key amino acid residues in the active site, (F)
  spirochromane derivative (control) bound to AKT key amino acid residues in the active
  site.
article_title: Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through
  PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells.
citation: Safaa M. Kishk, et al. Molecules. 2022 Oct;27(19):6709.
year: '2022'

doi: 10.3390/molecules27196709
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI

keywords:
- coumarin derivatives
- MTT assay
- apoptosis
- PI3K/AKT
- docking
- drug discovery
- industrial development

---
